Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Christopher J. Nardo
Observed names:
C J NARDO,
C. J. Nardo,
C. Nardo,
Christopher J Nardo,
Christopher Nardo,
Nardo, Christopher
show all 6
Institution:
Allergan (United States)
Observed institutions:
University of North Carolina at Chapel Hill,
National Institutes of Health,
University of Minnesota,
Johns Hopkins University,
National Heart, Lung, and Blood Institute,
Allergan (United States),
University of Bergen
show all 7
OpenAlex ID:
A5081090897
Non–Insulin-Dependent Diabetes Mellitus and Fasting Glucose and Insulin Concentrations Are Associated With Arterial Stiffness Indexes: The ARIC Study
1995
·
Veikko Salomaa
, Ward Riley
, et al.
·
Circulation
·
647
OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial
2013
·
Christopher Chapple
, Karl-Dietrich Sievert
, et al.
·
European Urology
·
456
OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial
2012
·
Victor W. Nitti
, Roger Dmochowski
, et al.
·
The Journal of Urology
·
445
OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial
2016
·
Victor W. Nitti
, Roger Dmochowski
, et al.
·
The Journal of Urology
·
334
Orthostatic hypotension and the incidence of coronary heart disease: the atherosclerosis risk in communities study
2000
·
K. M. Rose
, H. A. Tyroler
, et al.
·
American Journal of Hypertension
·
269
Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases
2017
·
Mark B. Faries
, Nicola Mozzillo
, et al.
·
Annals of Surgical Oncology
·
147
Descriptive Epidemiology of Blood Pressure Response to Change in Body Position: The ARIC Study
1999
·
Christopher J. Nardo
, Lloyd E. Chambless
, et al.
·
Hypertension
·
128
T cell receptor peptide vaccination in rheumatoid arthritis: A placebo-controlled trial using a combination of V3, V14, and V17 Peptides
1998
·
Larry W. Moreland
, Elizabeth E. Morgan
, et al.
·
Arthritis & Rheumatism
·
76
OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies used or reason for inadequate management of overactive bladder
2014
·
K.‐D. Sievert
, C. Chapple
, et al.
·
International Journal of Clinical Practice
·
65
PDF
Vaccination with a CDR2 BV6S2/6S5 peptide in adjuvant induces peptide‐specific T‐cell responses in patients with multiple sclerosis
2001
·
Elizabeth E. Morgan
, Christopher J. Nardo
, et al.
·
Journal of Neuroscience Research
·
21
Results of a Phase II Rheumatoid Arthritis Clinical Trial Using T-Cell Receptor Peptides
1999
·
S. W. Brostoff
, D. J. Carlo
, et al.
·
Springer eBooks
·
10
Predictors of HIV-specific lymphocyte proliferative immune responses induced by therapeutic vaccination
2002
·
R B MOSS
, M R WALLACE
, et al.
·
Clinical & Experimental Immunology
·
7
1367 Onabotulinumtoxina in Patients With Overactive Bladder and Urinary Incontinence: Consistent Effect Over Repeat Treatment
2013
·
Victor W. Nitti
, Karl-Dietrich Sievert
, et al.
·
The Journal of Urology
·
5
DMT310, a novel once-weekly topical treatment for patients with moderate-to-severe acne vulgaris: Results of a phase 2b randomized, double-blind, placebo-controlled trial
2023
·
Lawrence F. Eichenfield
, Janet C. DuBois
, et al.
·
Journal of the American Academy of Dermatology
·
4
741 Pivotal phase 3 study in overactive bladder (OAB) patients with urinary incontinence confirms onabotulinumtoxinA 100U significantly improves all OAB symptoms and patients' quality of life
2013
·
C. Chapple
, K-D. Sievert
, et al.
·
European Urology Supplements
·
3
Mp76-12 Overactive Bladder Patients ≥65 Years of Age Have a Similar Efficacy and Safety Profile With Onabotulinumtoxina as Patients <65 Years of Age
2014
·
Courtenay Moore
, Albert Kaufmann
, et al.
·
The Journal of Urology
·
2
Mp38-01 Long-term Efficacy and Safety of Repeat Onabotulinumtoxina Treatment in Overactive Bladder Syndrome and Urinary Incontinence: Third Interim Analysis, Median 2.4 Year Follow-up
2014
·
Victor Nitti
, Christopher Chapple
, et al.
·
The Journal of Urology
·
2
The Impact on Acne Treatment Regimens if Benzoyl Peroxide-Containing Products are Removed From the Market
2025
·
Sunil Dhawan
, Christopher J Nardo
·
Journal of Drugs in Dermatology
·
1
OnabotulinumtoxinA Significantly Decreases Urinary Incontinence and Provides Treatment Benefit in Patients with Idiopathic Overactive Bladder: A Pooled Analysis of Two Phase III, Placebo-Controlled Pivotal Trials
2013
·
Vikram Khullar
, Victor W. Νitti
, et al.
·
Neurourology and Urodynamics
·
1
OnabotulinumtoxinA Significantly Decreases Urinary Incontinence and Provides Treatment Benefit in Patients with Idiopathic Overactive Bladder
2012
·
Christopher R. Chapple
, Catherine Thompson
, et al.
·
ics.org
·
1
577 Consistent improvements in urinary urgency following repeat onabotulinumtoxinA treatments in patients with overactive bladder syndrome and urinary incontinence
2014
·
K-D. Sievert
, C.R. Chapple
, et al.
·
European Urology Supplements
Réduction significative des épisodes d’incontinence urinaire et amélioration de la qualité de vie des patients traités par onabotulinum toxine A : analyse groupée de deux études contre placebo de phase 3
2013
·
E. Chartier-Kastler
, K.D. Sievert
, et al.
·
The French Journal of Urology
744 OnabotulinumtoxinA 100U demonstrates similar treatment effect in overactive bladder patients with urinary incontinence regardless of number of prior anticholinergics taken or reason for their inadequate management of patients' overactive bladder
2013
·
C. Chapple
, K-D. Sievert
, et al.
·
European Urology Supplements
Clinically Meaningful Improvements in Urinary Incontinence and Quality of Life Over Multiple Treatment Cycles of OnabotulinumtoxinA in Patients with Overactive Bladder Syndrome and Urinary Incontinence: Interim Analysis of a Long-term Extension Study
2013
·
Victor W. Νitti
, Karl‐Dietrich Sievert
, et al.
·
Neurourology and Urodynamics
Show more works
View as search
Works count:
30
Citation count:
2,624
H-index:
10
I10-index:
11
Year
Topic
Type